Ansa Biotechnologies, Inc. — Form D
Ansa Biotechnologies, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-09. The offering totals $9.2M, of which $4.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-09
- Form: D
- Accession: 0001816722-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.2M
- Amount sold: $4.7M
- Remaining: $4.5M
- Investors: 24
- Date of first sale: 2020-06-24
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-370569
Issuer
- Name: Ansa Biotechnologies, Inc.
- CIK: 0001816722
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1198 65TH STREET #250, EMERYVILLE, CA, 94608
- Phone: 9256908100
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Daniel Hillel Lin-Arlow | Director | Berkeley, CA |
| Sebastian Hillel Palluk | Director | Berkeley, CA |
| Daniel Hillel Lin-Arlow | Executive Officer | Berkeley, CA |
| Sebastian Hillel Palluk | Executive Officer | Berkeley, CA |
| Jason T Gammack | Director | Emeryville, CA |
| Jason T Gammack | Executive Officer | Emeryville, CA |
| Yanniv T Dorone | Director | Emeryville, CA |
| Daniel T Lin-Arlow | Director | Emeryville, CA |
| Daniel T Lin-Arlow | Executive Officer | Emeryville, CA |
| Chenny T Zhang | Director | Emeryville, CA |
| Matthew T McManus | Director | Emeryville, CA |
| Sebastian T Palluk | Executive Officer | Emeryville, CA |
| Daniel Lin-Arlow | Director | Emeryville, CA |
| Daniel Lin-Arlow | Executive Officer | Emeryville, CA |
| Sebastian Palluk | Director | Emeryville, CA |
| Sebastian Palluk | Executive Officer | Emeryville, CA |
| Lily Li | Director | Emeryville, CA |
Other filings by this issuer (5)
More